(Note: This IPO is a unit offering. Each unit consists of one share of common stock and one warrant to buy one share of common stock. This is a NASDAQ listing with “BRSH” as the proposed stock symbol and “BRSHW” as the proposed symbol for the warrant.)  The company is on a mission to inspire […]

Note: This is an IPO of shares offered by YUKAI Health Group Ltd., a Cayman Islands-incorporated holding company. Our ordinary shares offered in this prospectus are shares of our Cayman Islands holding company, which has no material operations of its own and conducts substantially all of its operations through the subsidiaries established in the People’s Republic […]

African Agriculture, Inc. (“AA”, the “Company” or “we”), was incorporated in the State of Delaware on May 7, 2021. AA’s wholly owned subsidiary, Agro-Industries Corp., was incorporated in the Cayman Islands as an exempted company with limited liability, on Jan. 15, 2018. Our wholly owned Dakar-based subsidiary, Les Fermes de la Teranga SA (“LFT”) was organized in Senegal […]

We currently intend to focus on opportunities to acquire U.S. companies operating in the technology industry. (Incorporated in Delaware)  Cloud platform services, supply chain technologies, e-sports and companies serving hybrid work forces are among the businesses that we will consider for a business combination. Our management team is led by Arie Rabinowitz, our CEO and […]

(Apollo-backed SPAC Spartan Acquisition Corp. IV withdrew its SPAC IPO plans in an SEC filing dated June 29, 2022; this SPAC’s confidential IPO filing was made on March 3, 2021, and its S-1 was filed March 24, 2021.) We intend to focus our search on a target business in the energy value chain in North […]

Erayak Power Solution Group Inc. was formed in 2019 under the laws of the Cayman Islands. We conduct business primarily through our wholly owned subsidiaries, Zhejiang Leiya and Wenzhou New Focus, in the People’s Republic of China, or the PRC. Our company specializes in the manufacturing, research and development (“R&D”), and wholesale and retail of […]

We are a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. THIO will enter Phase 2 human trials (THIO-101) in Australia and Europe in the first half of 2022. Patients with advanced Non-Small Cell Lung Cancer (NSCLC) […]

We are a provider of integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. (Incorporated in the Cayman Islands) We use a fabless business model. We specialize in the front end and back end of IC design, which are the major components of the IC product development chain. We have established strong supply […]

(Note: Clearmind Medicine, Inc. priced its NASDAQ uplisting – a public offering of 1.15 million shares (1,153,847 shares) at $6.50 per share – on Nov. 14, 2022, to raise $7.48 million. The pricing terms represented fewer shares than in the prospectus – 1.15 million shares price, down from 1.26 million shares in the SEC filing […]

(Note: Switchback III Corp. withdrew its IPO plans in an SEC filing dated June 29, 2022. The SPAC, also known as a blank check company, filed its S-1 on Feb. 26, 2021. The company had planned to offer 27.5 million units at $10.00 each to raise $275 million. Each unit was to consist of common stock […]